Analysis of Radiopharmaceutical Synthesizer Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Worldwide revenue from the radiopharmaceutical synthesizers market is estimated to stand at US$ 6.6 billion in 2024 and is slated to increase at a CAGR of 8% to reach US$ 14.29 billion by 2034.
In nuclear medicine, radiopharmaceuticals are made using equipment called radiopharmaceutical synthesizers. These synthesizers combine radionuclides with other chemical substances to create specialized radiopharmaceuticals. Following synthesis, the radiopharmaceuticals are applied to medical treatments and diagnostic procedures, such as targeted radiation therapy and PET scans.
The market for radiopharmaceutical synthesizers is expected to increase steadily, with a good outlook currently in place. The growing incidences of chronic illnesses, developments in radiopharmaceutical research, and the need for customized treatment are some factors propelling the market.
Radiation-dependent PET-CT scanners are becoming increasingly popular, which is fueling the market's expansion. Detailed functional and anatomical information is provided by PET-CT imaging, which helps with early illness identification and precise diagnosis.
The advent of fully automated systems and enhanced synthesis processes, among other technological developments in radiopharmaceutical synthesizers, are driving market expansion. These developments lead to faster and more effective synthesis, which lowers the cost and manufacturing time of radiopharmaceuticals overall.
The market is anticipated to grow further because pharmaceutical corporations and academic institutions investing more in research and development. By creating new and improving, the ones that already exist; these investments hope to increase the range of applications for radiopharmaceutical synthesizers.
In conclusion, it is projected that the market will expand significantly during the next several years. Growth in the market is fueled by elements, including the growing incidence of chronic illnesses, technological developments, and more spending on R&D.
| Report Attribute | Detail |
|---|---|
| Radiopharmaceutical Synthesizer Market Size (2024E) | US$ 6.6 Billion |
| Forecasted Market Value (2034F) | US$ 14.29 Billion |
| Global Market Growth Rate (2024 to 2034) | 8% CAGR |
| North America Market Value (2024E) | US$ 2.3 Billion |
| Mexico Market Value (2034F) | US$ 295.3 Million |
| Hospitals Segment Growth Rate (2024 to 2034) | 8% CAGR |
| Canada Market Value (2034F) | US$ 612 Million |
| Key Companies Profiled | IBA; Elysia; IAEA; Advison Inc.; Advanced Cycolotron Systems; JSC Isotope; Lantheus Medical Imaging; BV Cyclotron UV; LabLogic Systems Ltd; NorthStar Medical Technologies |
Radiopharmaceutical synthesizers make pharmaceutical products, which contain small amounts of radioisotopes by irradiating a specific target, which are found inside a nuclear research reactor or in a particle accelerator. Once these radioisotopes are produced, they are tagged on certain molecules based on biological capabilities, which results in radiopharmaceuticals.
As with any medical or pharmaceutical product, radiopharmaceuticals are required to be produced under carefully controlled conditions and are subject to stringent tests for their quality before they are made commercially available.
More than 100 radiopharmaceuticals have been developed, using radioisotopes, which were either produced through nuclear reactors or particle accelerators. Radiopharmaceuticals are used to diagnose various medical problems like cardiac anomalies or neurological conditions and are used to treat certain conditions, such as cancers.
In 2018, the United States FDA and nuclear regulatory authority took steps in order to ensure the supply of a critical radioisotope, which is used as an imaging tracer to detect life-threatening diseases. The FDA approved NorthStar Medical Radioisotopes’ RadioGenix system, which is a unique system used for producing molybdenum-99 (Mo-99), a medical radioisotope.
Primary factors driving the radiopharmaceutical synthesizer market include the growing need for safe and effective guiding technology during the diagnosis and prognosis of various medical anomalies. Besides, the need for accurate procedures to diagnose cardiac neurological, and cancerous diseases the discovery of new radiopharmaceuticals has contributed to the growth in demand for radiopharmaceutical synthesizers across all end users.
Other than the increasing incidences of various anomalies, increasing awareness amongst the masses and an expanding application segment are driving the growth of the market. However, unawareness of the procedure in some developing countries is the factor limiting the growth of the global market, as opined in the radiopharmaceutical synthesizer industry outlook.
The global market for radiopharmaceutical synthesizers is highly consolidated with several players operating in the global space. Combined approaches of using radiopharmaceutical synthesizers with several research and development companies to obtain accurate diagnosis and prognosis of conditions, such as cancer treatment is increasing over the period, which is expected to create high demand for radiopharmaceutical synthesizers in diagnostic applications.
Some of the well-established players in the market are IBA, Elysia, IAEA, Advion, Inc., Advanced Cyclotron Systems, and JSC Isotope, which are studied thoroughly in the radiopharmaceutical synthesizer industry analysis.
Geographically, the global radiopharmaceutical synthesizer market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to be the leader in the global market owing to the focus on key market players in the region.
The market in Asia Pacific excluding is expected to grow at significant CAGR due to expansion of product offerings by key players. Europe is expected to take a noteworthy share of the global market throughout the forecast period.
Examples of some of the major players in the global market are Mercurius Health, IBA, Elysia, IAEA, Advion, Inc., Advanced Cyclotron Systems, JSC Isotope, Lantheus Medical Imaging, Inc., BV Cyclotron VU, LabLogic Systems Ltd, NorthStar Medical Technologies Technological advancement in already marketed products is the major trend.
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The radiopharmaceutical synthesizer industry analysis also maps the qualitative impact of several market factors on segments and geographies.
Why is the demand for radiopharmaceutical synthesizers increasing?
Growing requirement for safe and effective guiding technology for the diagnosis & prognosis of certain medical problems is increasing demand.
Which factor is adversely affecting the radiopharmaceutical synthesizer industry outlook?
Lack of information in developing economies brings down the sales of radiopharmaceutical synthesizers.
Which region is analyzed to remain dominant in the global radiopharmaceutical synthesizer market?
North America will remain the leading market for radiopharmaceutical synthesizers.
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Production Type
Table 3: Global Market US$ Mn Forecast by Indications
Table 4: Global Market US$ Mn Forecast by End User
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Production Type
Table 7: North America Market US$ Mn Forecast by Indications
Table 8: North America Market US$ Mn Forecast by End User
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Production Type
Table 11: Latin America Market US$ Mn Forecast by Indications
Table 12: Latin America Market US$ Mn Forecast by End User
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Production Type
Table 15: Western Europe Market US$ Mn Forecast by Indications
Table 16: Western Europe Market US$ Mn Forecast by End User
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Production Type
Table 19: Eastern Europe Market US$ Mn Forecast by Indications
Table 20: Eastern Europe Market US$ Mn Forecast by End User
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Production Type
Table 23: East Asia Market US$ Mn Forecast by Indications
Table 24: East Asia Market US$ Mn Forecast by End User
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Production Type
Table 27: South Asia & Pacific Market US$ Mn Forecast by Indications
Table 28: South Asia & Pacific Market US$ Mn Forecast by End User
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Production Type
Table 31: MEA Market US$ Mn Forecast by Indications
Table 32: MEA Market US$ Mn Forecast by End User
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Radiopharmaceutical Synthesizer Market